Incidence and natural course of fatty liver in the general population: The Dionysos study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Hepatology

• Publication date

  2007-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/hep.21827PMID 17685472
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study

  2007influential reference
• The Natural History of Nonalcoholic Fatty Liver Disease: A Population Based Cohort Study

  2006cited by this paper
• Long‐term follow‐up of patients with NAFLD and elevated liver enzymes

  2006cited by this paper
• Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious

  2006cited by this paper
• The Epidemiology of Nonalcoholic Fatty Liver Disease in Adults

  2006cited by this paper
• Prevalence of primary non‐alcoholic fatty liver disease in a population‐based study and its association with biochemical and anthropometric measures

  2006cited by this paper
• Natural History of Nonalcoholic Steatohepatitis

  2006cited by this paper
• The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population

  2006cited by this paper
• The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease

  2006cited by this paper
• Dichotomizing continuous predictors in multiple regression: a bad idea

  2006influential reference
• The metabolic syndrome as a predictor of nonalcoholic fatty liver disease.

  2006cited by this paper
• Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study

  2005cited by this paper
• The natural history of nonalcoholic fatty liver disease: a population-based cohort study.

  2005influential reference
• Natural history of NAFLD: remarkably benign in the absence of cirrhosis.

  2005cited by this paper
• Prevalence of and risk factors for fatty liver in a general population of Shanghai, China.

  2005cited by this paper
• A modified poisson regression approach to prospective studies with binary data.

  2004cited by this paper
• Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

  2003influential reference
• Hepatology

  2003cited by this paper
• Patterns of alcohol consumption in 10 European countries participating in the European Prospective Investigation into Cancer and Nutrition (EPIC) project

  2002influential reference
• The spectrum of liver disease in the general population: lesson from the Dionysos study.

  2001influential reference
• Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy

  2000cited by this paper
• Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study

  1999influential reference
• The use of fractional polynomials to model continuous risk variables in epidemiology.

  1999cited by this paper
• Vitamin C intake and susceptibility to pneumonia.

  1997cited by this paper
• Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres.

  1997influential reference
• Prevalence of chronic liver disease in the general population of northern Italy: The dionysos study

  1994cited by this paper

• Body mass index and metabolic dysfunction associated steatotic liver disease remission among Chinese adults in a retrospective cohort study

  2026cites this paper
• Is light-to-moderate alcohol drinking associated with the onset of metabolic dysfunction-associated steatotic liver disease in a Chinese cohort?

  2025cites this paper
• Effect of Testosterone Therapy (TTh) on Liver Function and Steatosis

  2025cites this paper
• The relationship between changes in alcohol consumption and hepatic steatosis among alcohol consumers: a large-scale population-based Biobank study

  2025cites this paper
• The relationship between zonulin level and indicators of carbohydrate metabolism in patients with metabolic-associated fatty liver disease combined with type 2 diabetes mellitus

  2023cites this paper
• The Effect of Bioactive Aliment Compounds and Micronutrients on Non-Alcoholic Fatty Liver Disease

  2023cites this paper
• Fatty Liver Index and mortality after myocardial infarction: A prospective analysis in the Alpha Omega Cohort

  2023cites this paper
• Nonalcoholic Fatty Liver Disease Incidence and Remission and Their Predictors During 7 Years of Follow-up Among Finns

  2023cites this paper
• A Current Approach to Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients

  2023influential citation
• Anti-Angiogenic Effects of Natural Compounds in Diet-Associated Hepatic Inflammation

  2023cites this paper
• First-in-human diagnostic study of hepatic steatosis with computed ultrasound tomography in echo mode

  2023cites this paper
• Probiotics as Potential Therapy in the Management of Non-Alcoholic Fatty Liver Disease (NAFLD)

  2023cites this paper
• The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease

  2023cites this paper
• Correlation between hepatorenal index and attenuation imaging for assessing hepatic steatosis

  2022cites this paper
• Geographical similarity and differences in the burden and genetic predisposition of NAFLD

  2022cites this paper
• four: Changing nutrition and non-alcoholic fatty liver disease (NAFLD) Non-alcoholic fatty liver disease: a multi-system disease in fl uenced by ageing and sex, and affected by adipose tissue and intestinal function

  2022cites this paper
• Annals of Hepatology

  2022cites this paper
• Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome in Women: Effects of Lifestyle Modifications

  2022cites this paper
• Ethnic and sex differences in hepatic lipid content and related cardiometabolic parameters in lean individuals

  2022cites this paper
• The Association Between the Dietary Inflammatory Index (DII) and Some Serum Oxidative Stress Markers in Non-Alcoholic Fatty Liver Disease: Case- Control

  2022cites this paper
• The associations between changes in hepatic steatosis and heart failure and mortality: a nationwide cohort study

  2022cites this paper
• The association between changes in hepatic steatosis and hepatic fibrosis with cardiovascular outcomes and mortality in patients with New-Onset type 2 Diabetes: A nationwide cohort study.

  2022cites this paper
• A blend of Sphaeranthus indicus flower head and Terminalia chebula fruit extracts reduces fatty liver and improves liver function in non-alcoholic, overweight adults

  2022cites this paper
• Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms

  2021cites this paper
• Complications of Obesity

  2021cites this paper
• Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease

  2021cites this paper
• Non-alcoholic fatty liver disease (NAFLD): a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function.

  2021cites this paper
• Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study

  2021cites this paper
• Method for diagnosing non-alcoholic liver steatosis

  2021cites this paper
• Age, Gender and Geographic Differences in Global Health Burden of Cirrhosis and Liver Cancer due to Nonalcoholic Steatohepatitis

  2021cites this paper
• Remnant Lipoprotein Cholesterol as a Factor Related to Adult Fatty Liver Disease.

  2021cites this paper
• Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.

  2021cites this paper
• Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis.

  2021cites this paper
• The associations between physical activity intensity, cardiorespiratory fitness, and non‐alcoholic fatty liver disease

  2021cites this paper
• Noninvasive Risk Stratification for Nonalcoholic Fatty Liver Disease Among Living Liver Donor Candidates: A Proposed Algorithm

  2021cites this paper
• The Repeatedly Elevated Fatty Liver Index Is Associated With Increased Mortality: A Population-Based Cohort Study

  2021cites this paper
• Is there a link between non-alcoholic fatty liver disease aspects and pancreatic cancer? Results of a case-matched study

  2021cites this paper
• Epidemiology of non-alcoholic fatty liver disease in Asia

  2020cites this paper
• NAFLD 2020: The State of the Disease.

  2020cites this paper
• Epidemiology of non-alcoholic and alcoholic fatty liver diseases.

  2020cites this paper
• Association of Apolipoprotein C3 Levels and Hepatic Steatosis: A Follow-Up Study

  2020cites this paper
• Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis.

  2020cites this paper
• A nomogram for estimating the probability of nonalcoholic fatty liver disease in a Chinese population

  2020cites this paper
• Die nicht-alkoholische Fettleber-Erkrankung

  2020cites this paper
• Non-Alcoholic Fatty Liver Disease and its Interplay with Various Metabolic Disorders

  2020cites this paper
• Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study

  2020cites this paper
• Relationship between non-alcoholic fatty liver disease and coronary heart disease

  2020cites this paper
• Spectrum of liver diseases in patients referred for Fibroscan: A single center experience in the Middle East

  2020cites this paper
• Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities

  2020cites this paper
• PPARγ gene Pro12Ala variants reduce the risk of obese individuals to non-alcoholic fatty liver: A study in Uygur Chinese population residing in Northwestern China.

  2020cites this paper
• THE EFFECTS OF REALSIL (SILYBIN-PHOSPHOLIPID-VITAMIN E COMPLEX) ON LIVER ENZYMES IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) OR NON-ALCOHOLIC STEATO-HEPATITIS (NASH): A SYSTEMATIC REVIEW AND META-ANALYSIS OF RCTS.

  2020cites this paper
• Nonalcoholic fatty liver disease and cardiovascular disease phenotypes

  2020cites this paper
• Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease

  2020cites this paper
• The Incidence and Risk Factors of Non-Alcoholic Fatty Liver Disease: A Cohort Study from Iran

  2020cites this paper
• Silymarin-Extrakt aus Silybum marianum (L.) Gaertn. gegen alimentär-toxische Leberschäden?

  2020cites this paper
• Non-invasive diagnosis of nonalcoholic fatty liver disease: impact of age and other risk factors

  2020cites this paper
• Syndrome métabolique et chirurgie hépatique

  2020cites this paper
• Prevalence and severity of non-alcoholic fatty liver disease in patients with gall stone disease

  2020cites this paper
• Non-alcoholic fatty liver disease in adults: Current concepts in etiology, outcomes and management.

  2019cites this paper
• Modeling the natural history of fatty liver using lifestyle–related risk factors: Effects of body mass index (BMI) on the life–course of fatty liver

  2019cites this paper
• Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study

  2019cites this paper
• Liver-related complications and metabolic comorbidities during long-term follow-up of patients with Non-Alcoholic Fatty Liver Disease

  2019cites this paper
• [Nutritional steatosis a drug target, or more especially anchor point for a holistic approach?]

  2019cites this paper
• Mechanistic Studies of Cholesterol Lipotoxicity Pertinent to NASH

  2019cites this paper
• High prevalence of non‐alcoholic fatty liver disease among healthy male blood donors of urban India

  2019cites this paper
• Drug-induced liver steatosis in patients with HIV infection.

  2019cites this paper
• Diagnosis and management of non-alcoholic fatty liver disease

  2019cites this paper
• Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity

  2019cites this paper
• Hepatic steatosis in patients undergoing resection of colorectal liver metastases: A target for prehabilitation? A narrative review.

  2019cites this paper
• Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?

  2019cites this paper
• Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications

  2019cites this paper
• The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.

  2019cites this paper
• Soup Kitchens: Homeless Adults and Gaps in Meeting Their Nutritional Needs

  2019cites this paper
• Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.

  2019cites this paper
• Metabolic syndrome and hepatic surgery.

  2019cites this paper
• 6‐gingerol ameliorates age‐related hepatic steatosis: Association with regulating lipogenesis, fatty acid oxidation, oxidative stress and mitochondrial dysfunction

  2019cites this paper
• Non-alcoholic fatty liver disease incidence, remission and risk factors among a general Chinese population with a 6-year follow-up

  2018cites this paper
• Nutritional supplementation for non-alcohol-related fatty liver disease: a network meta-analysis

  2018cites this paper
• Metabolic syndrome. Topical issues of diagnosis, pathogenesis and rehabilitation

  2018cites this paper
• A systematic review of the present and future of non-alcoholic fatty liver disease

  2018cites this paper
• Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study

  2018cites this paper
• Non-HDL-cholesterol to HDL-cholesterol ratio is a better predictor of new-onset non-alcoholic fatty liver disease than non-HDL-cholesterol: a cohort study

  2018cites this paper
• The Severity of Non-Alcoholic Fatty Liver in Type II Diabetes

  2018cites this paper
• Increased risk of nonalcoholic fatty liver disease in patients with coeliac disease on a gluten‐free diet: beyond traditional metabolic factors

  2018cites this paper
• Valoración de la enfermedad por hígado graso no alcohólico desde el laboratorio clínico

  2018cites this paper
• Reducing NAFLD‐screening time: A comparative study of eight diagnostic methods offering an alternative to ultrasound scans

  2018cites this paper
• Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC.

  2018cites this paper
• Modeling the Natural History of Non-Alcoholic Fatty Liver Disease : Impact of Reduction in Body Mass Index and / or Cholesterol on the Prevalence of NAFLD

  2018cites this paper
• Insights into the Epidemiology, Pathogenesis, and Therapeutics of Nonalcoholic Fatty Liver Diseases

  2018cites this paper
• Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease.

  2018cites this paper
• Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes

  2018cites this paper
• Progression and new onset of nonalcoholic fatty liver disease in living kidney donors compared to healthy controls

  2018cites this paper
• A simple clinical model predicts incident hepatic steatosis in a community‐based cohort: The Framingham Heart Study

  2018influential citation
• Lifestyle modifications for non-alcohol related fatty liver disease: a network meta-analysis

  2018cites this paper
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  2018cites this paper
• A study of the Role of 25 Hydroxy-Cholecalciferol Level on Non Alcoholic Fatty Liver Disease (NAFLD) in a Cohort of Egyptian Patients

  2018cites this paper
• The Liver: General Aspects and Epidemiology

  2017cites this paper
• Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study

  2017cites this paper
• Evaluation of Liver Enzyme Elevation and Its Contributing Factors in Birjand, Iran

  2017cites this paper